On 7 June 2022, 19 October 2021, 4 April 2022, 29 March 2023, 25 January 2022, 6 May 2024, 24 July 2023 and 4 January 2022, the rapporteur Member State for the active substances 1-decanol, 6-benzyladenine, aluminium sulfate, dodine, fluometuron, pinoxaden, prosulfuron and sintofen, respectively, informed the co-rapporteur Member State, the Commission and the Authority that it had assessed the admissibility pursuant to Article 8 of Implementing Regulation (EU) 2020/1740, and in particular the completeness and the timeliness of each of the applications for renewal of the approval of each of those active substances and concluded that they were admissible. Those applications have been made public by the Authority pursuant to Article 10 of Implementing Regulation (EU) 2020/1740.
Recital 47, Regulation (EU) 2026/372
In forcesince 20 Feb 2026